Form D · Biotechnology

DIATHERIX, Inc.

Huntsville, AL · CIK 0001492026

Offering snapshot reported Jan 4, 2012 · SEC filing

Reported sold
$630K
Offering amount: $1M
Investors reported
6
Form D · investor count
Minimum accepted
$80K
Reported outside-investor minimum
First sale
Dec 1, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$315K$630KDec 14, 2011: $100,005.00Dec 14, 2011Jan 4, 2012: $630,030.00Jan 4, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$100,005 → $630,030
  • Reported investors1 → 6
  • Minimum accepted$100,005 → $80,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 4, 2012Amendment$630,030$530,025vs Dec 14, 20116SEC filing
Dec 14, 2011Initial$100,005No comparison1SEC filing
May 14, 2010Initial$990,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-170013

Source: Form D, filed Jan 4, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mei Lu Chiung Director
Dennis Grimaud Director, Executive
Brian House Executive
Cheri Walker Director
James Ward Director, Executive
Susan Whitehead Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
601 Genome Way, Suite 4208
Huntsville, AL, 35806